A Complete Guide to Identifying and Treating Co-Occurring Mental Health and Substance Use Disorders

Mental health and substance use problems don’t develop in a vacuum. There’s a more complicated story that can help make these issues more clear. And, maybe more importantly, open up new ways of addressing them.

The bidirectional relationship between mental illness and drug addiction

Many assume that substance abuse triggers mental health issues, while others believe that mental disorders drive individuals to use drugs. The reality is that both scenarios occur, which makes it all the more complex.

For example, a person with untreated anxiety may begin to drink alcohol in social settings. As their alcohol use gets out of control, their anxiety will intensify and may become more persistent. The anxiety will continue to worsen as the person is sober, leading them to drink more to calm their fears. The two disorders begin to exacerbate each other. Neither a psychiatrist nor a substance abuse counselor will be able to effectively address the causes of this situation if they don’t work together.

This is also the basis of the self-medication hypothesis. It states that individuals struggling with an untreated psychiatric disorder often turn to drugs and alcohol to alleviate their symptoms, not initially for the high they get. People who have Post Traumatic Stress Disorder (PTSD) and use opioids to stupefy themselves fall almost exactly into this category.

The biopsychosocial model of causation is one of the best frameworks for conceptualizing how the complex interactions of genetics, biology, development, and social expectations may lead someone to develop the disease of addiction. This model looks at how all of these factors interact and how the presence of any or all of these factors can encourage the development of addiction.

Recognizing the clinical signs of a dual diagnosis

A dual diagnosis isn’t just someone who drinks too much and also feels sad. The clinical picture is specific, and it matters to recognize it correctly.

Some of the clearest signs include mood swings that persist well into periods of sobriety, difficulty functioning in daily life even when substances aren’t actively involved, using alcohol or drugs specifically to manage anxiety or emotional distress in social settings, and histories of trauma that were never treated directly. You’ll also see patterns where someone can stop using for a period of time but becomes severely destabilized mentally – suicidal ideation, paranoia, extreme mood episodes – suggesting the underlying psychiatric condition hasn’t been addressed at all.

The DSM-5 provides the diagnostic criteria clinicians use to sort through what’s happening. Getting this right takes time because withdrawal symptoms can mimic or mask psychiatric conditions. Someone in opiate withdrawal looks severely depressed. Someone coming off stimulants can present with what looks like major psychotic disorder. This is where diagnostic overshadowing becomes a real clinical hazard.

Diagnostic overshadowing happens when the substance use is so visible and urgent that clinicians focus entirely on it, effectively treating the psychiatric condition as a byproduct rather than a parallel primary diagnosis. The result is that patients get sober, the psychiatric symptoms surface without the substances suppressing them, and without proper psychiatric support in place, relapse follows quickly. It’s one of the most common reasons early treatment attempts fail.

Approximately 9.2 million adults experienced both a mental illness and a substance use disorder in a single year (SAMHSA, National Survey on Drug Use and Health).

Why treating these disorders in sequence or separately fails

The traditional model involved treating addiction in one facility and mental health in another. Or getting someone stable on addiction medications, then treating their depression. This thinking was later proven to be ineffective for patients with both conditions.

First, you generally can’t stabilize someone’s addiction if the underlying psychiatric condition is going untreated (or is undertreated). Send a patient home from detox with a supply of Suboxone or buprenorphine to treat their opioid dependence without adequately diagnosing or treating their depression, and you’re likely sending them back to the same environment many had been using opioids to escape.

Running an addiction and a mental health program in parallel, such as sending a patient to addiction counseling and to see a psychiatrist or therapist without the two care teams communicating, was another example of how this ‘sequential’ model broke down.

Two different philosophies and medication protocols – addiction specialists slapping you on the back and congratulating you for quitting while mental health professionals scolded you for relapsing, for example – would lead to fragmented, frustrating care that left many patients vulnerable to falling through the gaps.

Integrated treatment isn’t a sequential program but one where you’re addressing both conditions at the same time. Facilities like https://legacyhealingohio.com/ represent this model – where dual-diagnosis care isn’t a specialty add-on but the foundational structure of the program. Treating both conditions simultaneously makes more sense, from both a logical and an outcomes perspective.

What evidence-based therapy looks like in dual-diagnosis treatment

Two psychotherapy models have proven especially effective in treating co-occurring disorders: Cognitive Behavioral Therapy and Dialectical Behavior Therapy. Not only are they not interchangeable, but therapists need to know the precise differences between the two approaches. They may seem slight on the surface, yet they address two competing ways that clients can fail at recovery.

Cognitive Behavioral Therapy works by helping patients map the specific thought process that connects their emotional states to their drug use or drinking. For example, a patient with depression may think to themselves that nothing will ever improve – and that thought removes the motivation to remain sober. That thought can be directly challenged, and in CBT, it’s replaced with a more accurate and motivationally sound one. In dual-diagnosis cases, this process is adapted to map the relationship between mental health and using triggers, and patients move between the strategies less predictably.

Dialectical Behavior Therapy was developed to treat borderline personality disorder, but it may be the single most effective modality for dual-diagnosis patients. This therapy is based on teaching four sets of skill: mindfulness, distress tolerance, emotional regulation, and interpersonal effectiveness. If the patient has been subjected to trauma and continues to experience severe mood swings, severe mood elevation or decline, or else has a history of impulsively using drugs during times of emotional upset, then this treatment exposes – and provides concrete techniques for – the states that they’re trapped in.

Medical detoxification in dual-diagnosis patients

Detox for someone with a co-occurring psychiatric disorder is medically more complex than standard withdrawal management. It can’t be done in isolation from psychiatric care.

Withdrawal from alcohol can cause severe anxiety, perceptual disturbances, and in some cases full psychosis – and in someone with an underlying mood disorder or schizophrenia, these symptoms can become dangerous quickly. Opioid withdrawal produces profound depression that in a dual-diagnosis patient isn’t just temporary discomfort but a potential psychiatric emergency. Stimulant withdrawal brings on extended depressive episodes that look clinically indistinguishable from major depressive disorder.

Medical detoxification in a dual-diagnosis program requires psychiatric monitoring throughout the process, not just medical management of physical withdrawal symptoms. Clinicians need to watch for the emergence or worsening of psychiatric conditions as substances clear the system, adjust psychiatric medications accordingly, and keep the patient psychologically stable enough to begin meaningful therapeutic work once detox is complete.

Trying to manage this without psychiatric oversight – or in a facility that doesn’t have it – creates significant risk.

Pharmacological considerations in integrated care

Medication is a useful tool in dual-diagnosis treatment, and the concern that psychiatric medication will interfere with recovery or trigger drug addiction is largely unfounded when prescribing is handled correctly.

Non-addictive psychiatric medications – antidepressants, mood stabilizers, non-benzodiazepine anxiolytics, antipsychotics – are routinely and safely used in recovery. The key is that the prescribing psychiatrist understands the patient’s full history, including substance use, and the medication plan is coordinated with the broader treatment team.

The decision about whether to prescribe, what to prescribe, and at what dosage has to account for neuroplasticity – the brain’s ability to reorganize itself over time during sobriety. In early recovery, the brain is still recalibrating its baseline chemistry after prolonged substance exposure. Medication decisions made in the first weeks need to be revisited as that stabilization progresses. This is a process, not a single prescription event.

Relapse prevention and the role of family support

A strong relapse prevention plan must be precise. It cannot simply state "avoid triggers." Instead, it should outline exactly what those triggers are for the individual patient, identify the unique early warning signs of mental health deterioration and substance craving, and establish a plan of action to follow when those signs present themselves.

For patients with dual diagnoses, both disorders must be considered in the relapse prevention process. A mental health episode can be a trigger for relapse, just as a substance use slip can destabilize the psychiatric condition. These are interconnected within the prevention plan, just as they are in treatment.

Family and support systems are important in this process, but they must be given clear guidance on their role. Enabling behaviors (i.e., covering up the problem, underplaying the severity of the situation, shielding the person with the substance use disorder from consequences that need to happen) can undermine recovery efforts, even if they stem from a place of love and concern. Supportive behaviors tend to foster consistent style boundaries, an early recognition of warning signs, and an understanding of the progressive, non-linear development of recovery.

The associated warning signs may include isolation or withdrawal from relationships, changes in sleep, increased irritability or emotional sensitivity, and the return of language or behaviors that accompanied the period of active use. These are warning signs, not guarantees. However, the repetition of these behaviors should be cause for concern.

Getting to the right level of care

The difference between treatment that works and treatment that doesn’t is almost always about whether both conditions were taken seriously at the same time. Dual diagnosis isn’t a complication – it’s just the accurate clinical picture for a large percentage of people seeking help with addiction. The framework exists. The therapies exist. The question is finding a program that actually delivers integrated care rather than just using the language around it.